1. |
Thomas H. Pancreatic cancer: intra-tumour bacteria promote gemcitabine resistance in pancreatic adenocarcinoma. Nat Rev Gastroenterol Hepatol, 2017, 14(11): 632.
|
2. |
Chin V, Nagrial A, Sjoquist K, et al. Chemotherapy and radiotherapy for advanced pancreatic cancer. Cochrane Database Syst Rev, 2018, 3: CD011044.
|
3. |
Vienot A, Beinse G, Louvet C, et al. Overall survival prediction and usefulness of second-line chemotherapy in advanced pancreatic adenocarcinoma. J Natl Cancer Inst, 2017, 109(10): 10.
|
4. |
Udumyan R, Montgomery S, Fang F, et al. Beta-blocker drug use and survival among patients with pancreatic adenocarcinoma. Cancer Res, 2017, 77(13): 3700-3707.
|
5. |
Treiber T, Treiber N, Plessmann U, et al. A compendium of RNA-binding proteins that regulate microRNA biogenesis. Mol Cell, 2017, 66(2): 270-284.
|
6. |
Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol, 2018, 141(4): 1202-1207.
|
7. |
López-González MJ, Landry M, Favereaux A. MicroRNA and chronic pain: from mechanisms to therapeutic potential. Pharmacol Ther, 2017, 180: 1-15.
|
8. |
Rapado-González Ó, Majem B, Muinelo-Romay L, et al. Human salivary microRNAs in cancer. J Cancer, 2018, 9(4): 638-649.
|
9. |
Kanno S, Nosho K, Ishigami K, et al. MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer. Carcinogenesis, 2017, 38(4): 425-431.
|
10. |
Idichi T, Seki N, Kurahara H, et al. Regulation of actin-binding protein ANLN by antitumor. Oncotarget, 2017, 8(32): 53180-53193.
|
11. |
Xia H, Ooi LL, Hui KM. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer. Hepatology, 2013, 58(2): 629-641.
|
12. |
Xue Y, Ouyang K, Huang J, et al. Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits. Cell, 2013, 152(1-2): 82-96.
|
13. |
Liu L, Aleksandrowicz E, Schönsiegel F, et al. Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1. Cell Death Dis, 2017, 8(10): e3064.
|
14. |
Huang PH, Lu PJ, Ding LY, et al. TGFβ promotes mesenchymal phenotype of pancreatic cancer cells, in part, through epigenetic activation of VAV1. Oncogene, 2017, 36(16): 2202-2214.
|
15. |
杨尹默, 刘子文, 赵玉沛, 等. 胰腺癌诊治指南 (2014). 中国实用外科杂志, 2014, 34(11): 1011-1017.
|
16. |
Wald P, Liu XS, Pettit C, et al. Prognostic value of microRNA expression levels in pancreatic adenocarcinoma: a review of the literature. Oncotarget, 2017, 8(42): 73345-73361.
|
17. |
Negoi I, Hostiuc S, Sartelli M, et al. MicroRNA-21 as a prognostic biomarker in patients with pancreatic cancer-a systematic review and meta-analysis. Am J Surg, 2017, 214(3): 515-524.
|
18. |
Li CH, Xiao Z, Tong JH, et al. EZH2 coupled with HOTAIR to silence MicroRNA-34a by the induction of heterochromatin formation in human pancreatic ductal adenocarcinoma. Int J Cancer, 2017, 140(1): 120-129.
|
19. |
Yi JM, Kang EJ, Kwon HM, et al. Epigenetically altered miR-1247 functions as a tumor suppressor in pancreatic cancer. Oncotarget, 2017, 8(16): 26600-26612.
|
20. |
Liu S, Chen S, Zeng J. TGF-β signaling: a complex role in tumorigenesis (review). Mol Med Rep, 2018, 17(1): 699-704.
|
21. |
Zhao Y, Qiao W, Wang X, et al. 14-3-3ζ/TGFβR1 promotes tumor metastasis in lung squamous cell carcinoma. Oncotarget, 2016, 7(50): 82972-82984.
|
22. |
Hu Q, Hisamatsu T, Haemmerle M, et al. Role of platelet-derived Tgfβ1 in the progression of ovarian cancer. Clin Cancer Res, 2017, 23(18): 5611-5621.
|
23. |
Craven KE, Gore J, Wilson JL, et al. Angiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomes. Oncotarget, 2016, 7(1): 323-341.
|
24. |
Principe DR, Diaz AM, Torres C, et al. TGFβ engages MEK/ERK to differentially regulate benign and malignant pancreas cell function. Oncogene, 2017, 36(30): 4336-4348.
|
25. |
Xu X, Chen R, Li Z, et al. MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1. BMC Cancer, 2015, 15: 1023.
|